A RANDOMIZED STUDY OF THE INFLUENCE OF PERFUSION TECHNIQUE AND PH MANAGEMENT STRATEGY IN 316 PATIENTS UNDERGOING CORONARY-ARTERY BYPASS-SURGERY .1. MORTALITY AND CARDIOVASCULAR MORBIDITY

被引:79
作者
MURKIN, JM
MARTZKE, JS
BUCHAN, AM
BENTLEY, C
WONG, CJ
机构
[1] ROBARTS RES INST,CLIN TRIALS RESOURCES GRP,LONDON,ON,CANADA
[2] VANCOUVER HOSP & HLTH SCI CTR,DEPT PSYCHOL,VANCOUVER,BC,CANADA
[3] UNIV OTTAWA,CIV HOSP,DEPT NEUROL,OTTAWA,ON,CANADA
关键词
D O I
10.1016/S0022-5223(95)70229-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The impact of perfusion technique and mode of pH management during cardiopulmonary bypass has not been well characterized with respect to postoperative cardiovascular outcome. Methods: This double-blind, randomized study comparing outcomes after alpha-stat or pH-stat management and pulsatile or nonpulsatile perfusion during moderate hypothermic cardiopulmonary bypass was undertaken in 316 patients undergoing coronary artery bypass operations. Results: Cardiovascular morbidity and mortality were not affected by pH management, and the incidence of stroke (2.5%) did not differ between groups. Overall in-hospital mortality was 2.8%, eight of the nine deaths occurring in the nonpulsatile group (5.1% versus 0.6%; p = 0.018). The incidence of myocardial infarction was 5.7% in the nonpulsatile group and 0.6% in the pulsatile group (p = 0.010), and use of intraaortic balloon pulsation was significantly more common in the nonpulsatile group (7.0% versus 1.9%; p = 0.029). The overall percentage of patients having major complications was also significantly higher in the nonpulsatile group (15.2% versus 5.7%; p = 0.006). Duration of cardiopulmonary bypass, age, and use of nonpulsatile perfusion all correlated significantly with adverse outcome. Conclusions: Use of pulsatile perfusion during cardiopulmonary bypass was associated with decreased incidences of myocardial infarction, death, and major complications.
引用
收藏
页码:340 / 348
页数:9
相关论文
共 41 条
[1]  
ALSTON RP, 1989, J THORAC CARDIOV SUR, V98, P757
[2]  
ALSTON RP, 1990, J THORAC CARDIOV SUR, V100, P134
[3]  
BADNER NH, 1992, ANESTH ANALG, V75, P696
[5]  
BECKER H, 1981, J THORAC CARDIOV SUR, V82, P810
[6]  
BIXLER TJ, 1979, CIRCULATION S, V60, P141
[7]  
BREGMAN D, 1977, CIRCULATION, V56, P157
[8]   PLASMA-RENIN ACTIVITY AND URINE BETA-2-MICROGLOBULIN DURING AND AFTER CARDIOPULMONARY BYPASS - PULSATILE VS NON-PULSATILE PERFUSION [J].
CANIVET, JL ;
LARBUISSON, R ;
DAMAS, P ;
BLAFFART, F ;
FAYMONVILLE, M ;
LIMET, R ;
LAMY, M .
EUROPEAN HEART JOURNAL, 1990, 11 (12) :1079-1082
[9]  
CHITWOOD WR, 1981, J SURG RES, V30, P553
[10]  
CIARDULLO RC, 1978, J THORAC CARDIOV SUR, V75, P193